Embio's plant is one of the finest bulk
drug plants in India. The state of the art
integrated manufacturing facility has the flexibility
to meet customer specifications and uses indigenous
and unique bio-synthetic processes. Safety, ease of
operations and cGMP has been the foundation of plant
design and equipment selection.
The
manufacturing facility includes various fermentors,
agitators, filter dryers, hydro generator, a pilot
plant, laboratories, solvent recovery plant, and
state of the art effluent treatment plant and
storage capacity for its products.
There
are two plants - Plant 1 and Plant 2.
Plant 1 is fully dedicated for producing Ephedrine
Hcl and consists of fermentation and synthetic
process.
Plant 2 is the Pseudo Ephedrine plant
and is used for converting Ephedrine Hcl
into Pseudo Ephedrine Hcl.
Embio
is today, only the second company in the world to
have achieved the following 3 regulatory milestones
The Australian TGA Approval
The US FDA Approval
The European Certificate of Suitability
for Pseudoephedrine HCl (CoS)
